查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1636685

器官保存解決方案市場預測至 2030 年：按器官類型、解決方案類型、分銷管道、應用和地區進行的全球分析

Organ Preservation Solutions Market Forecasts to 2030 - Global Analysis By Organ Type (Kidneys, Liver, Heart, Lungs, Pancreas and Other Organ Types), Solution Type, Distribution Channel, Application and By Geography
出版日期: | 出版商: Stratistics Market Research Consulting | 英文 200+ Pages | 商品交期: 2-3個工作天內

價格

根據 Stratistics MRC 的數據，全球器官保存解決方案市場預計在 2024 年將達到 2.73 億美元，到 2030 年預計將達到 4.213 億美元，預測期內的複合年成長率為 7.5%。

器官保存溶液是一種特殊的液體，用於在器官從捐贈者體內取出到移植到接受者體內期間維持器官的活力和功能。這些解決方案可防止細胞損傷、減少代謝活動並保護組織免受缺血性損傷，使器官仍適合移植。透過保持器官涼爽和防止通常導致器官劣化的生化過程，它對於維持器官結構和功能至關重要。

根據美國人口普查局的數據，到 2024 年，美國20% 的人口預計將年齡在 65 歲或以上，導致需要器官移植的與老齡化相關的疾病發生率很高。

器官衰竭發生率增加

由於老化、慢性病和生活方式相關的健康問題等因素導致的器官衰竭發病率不斷增加，大大推動了器官移植的需求。這推動了器官保存解決方案市場的成長。隨著需要移植的器官越來越多，長期維持器官活力的重要性推動了器官保存技術和解決方案的進步，從而促進了市場的擴張。

器官供應有限

市場上器官供應有限帶來了重大挑戰，包括增加器官移植的等待時間以及增加需要器官移植的患者的風險。這種短缺導致對次優保存方法的依賴，從而降低器官存活率和移植成功率。此外，由於需求遠遠超過供應，醫療保健系統被迫根據標準對患者進行優先排序，這往往使他們處於最脆弱的境地。

老年人口不斷增加

老化人口的不斷成長是器官保存解決方案需求的主要驅動力。由於老年人更容易出現與器官相關的健康問題並需要器官移植，對有效的器官保存方法的需求正在迅速增加。這種人口變化促進了器官保存技術的進步，確保了器官移植更長的存活時間和更好的結果。與老齡化相關的疾病發生率的增加和對移植解決方案的需求是該市場的主要成長要素。

治療費用高昂

該市場上的高昂手術費用可能會對醫療服務的可近性和可負擔性造成重大障礙，尤其是在資源匱乏的地區。這些成本可能會限制先進保存技術的可用性，並阻礙器官的及時運輸和移植。這可能導致器官移植成功率降低並破壞器官捐贈系統的整體效率，從而導致更長的等待時間和更高的死亡率。

COVID-19 的影響：

由於健康和安全問題，COVID-19 疫情推遲了選擇性手術並減少了器官捐贈，嚴重擾亂了市場。醫院面臨資源短缺，器官運輸因封鎖和旅行限制而受到阻礙。這些挑戰導致移植積壓，影響了患者的治療結果並減少了對保存解決方案的整體需求。此外，疫情也為這些關鍵醫療產品的供應鏈帶來了壓力。

器官移植領域預計將成為預測期內最大的領域

預計預測期內器官移植部分將佔據市場佔有率。有效的器官保存對於維持運輸過程中的器官活力和成功移植至關重要。隨著器官捐贈者的不斷增加，創新保存解決方案的需求也隨之增加，尤其是腎臟、肝臟和心臟等需求量大的器官。市場的成長與提高移植成功率和器官壽命的保存方法的進步密切相關。

預計預測期內生物防腐領域將以最高的複合年成長率成長。

預計預測期內生物防腐領域將以最高的複合年成長率成長。這種方法涉及冷凍保存或低溫保存技術，以保護器官免受冷凍和低溫造成的傷害。生物保存透過延長器官儲存時間、減少缺血性損傷和提高移植成功率來確保器官移植獲得更好的結果。其日益普及正在推動器官保存技術的創新和市場成長。

比最大的地區

預計預測期內北美地區將佔據最大的市場佔有率。該地區是研究和開發保存技術的溫床，包括低溫和常溫。政府對器官移植的措施和資助進一步推動了市場的成長。北美對高效保存解決方案的需求很高，這是由於提高移植成功率和減少器官排斥的需求。

複合年成長率最高的地區：

由於器官移植需求的不斷增加，預計亞太地區在預測期內將實現最高的成長率。由於器官衰竭以及糖尿病、心臟病等慢性疾病的發生率不斷上升，器官移植的需求也日益增加。此外，機器灌注和冷藏溶液等先進保存方法的發展提高了器官在運輸和儲存過程中的活力。

免費客製化服務

訂閱此報告的客戶可享有以下免費自訂選項之一：

  • 公司簡介
    • 全面分析其他市場參與者（最多 3 家公司）
    • 主要企業的 SWOT 分析（最多 3 家公司）
  • 地理細分
    • 根據客戶興趣對主要國家進行的市場估計、預測和複合年成長率（註：基於可行性檢查）
  • 競爭性基準化分析
    • 根據產品系列、地理分佈和策略聯盟對主要企業進行基準化分析

目錄

第1章執行摘要

第 2 章 前言

  • 概述
  • 相關利益者
  • 研究範圍
  • 調查方法
    • 資料探勘
    • 資料分析
    • 資料檢驗
    • 研究途徑
  • 研究資訊來源
    • 主要研究資訊來源
    • 二手研究資料資訊來源
    • 先決條件

第3章 市場走勢分析

  • 驅動程式
  • 限制因素
  • 機會
  • 威脅
  • 應用分析
  • 新興市場
  • COVID-19 的影響

第 4 章 波特五力分析

  • 供應商的議價能力
  • 買家的議價能力
  • 替代品的威脅
  • 新進入者的威脅
  • 競爭對手之間的競爭

5. 全球器官保存解決方案市場（按器官類型）

  • 腎
  • 肝
  • 心
  • 肺
  • 胰臟
  • 其他器官類型

6. 全球器官保存解決方案市場（依解決方案類型）

  • 防靜電解決方案
    • 威斯康辛大學 (UW) 解決方案
    • 柯林斯解決方案
    • Celsior 解決方案
    • 託管解決方案
  • 動態儲存解決方案
    • 常溫機灌注（NMP）
    • 低溫灌注機 (HMP)

7. 全球器官保存解決方案市場按分銷管道分類

  • 直接銷售
  • 分銷商/批發商
  • 網上銷售與電子商務

8. 全球器官保存解決方案市場（按應用）

  • 器官移植
  • 醫學研發
  • 藥物測試
  • 生物保存
  • 臨床和診斷
  • 器官獲取和運輸
  • 其他應用

9. 全球器官保存解決方案市場（按地區）

  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 德國
    • 英國
    • 義大利
    • 法國
    • 西班牙
    • 其他歐洲國家
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 澳洲
    • 紐西蘭
    • 韓國
    • 其他亞太地區
  • 南美洲
    • 阿根廷
    • 巴西
    • 智利
    • 南美洲其他地區
  • 中東和非洲
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 卡達
    • 南非
    • 其他中東和非洲地區

第10章 主要進展

  • 協議、夥伴關係、合作和合資企業
  • 收購與合併
  • 新產品發布
  • 業務擴展
  • 其他關鍵策略

第11章 公司概況

  • Thermo Fisher Scientific
  • Merck
  • Fisher Scientific
  • TSE Systems
  • Sorin Group
  • Eurobio Scientific
  • Baxter International
  • Medtronic
  • Teva Pharmaceuticals
  • Asahi Kasei Medical
  • Hemonetics
  • Organ Recovery Systems
  • TransMedics
  • Perfusion Solutions
  • Stemcell Technologies
Product Code: SMRC28326

According to Stratistics MRC, the Global Organ Preservation Solutions Market is accounted for $273.0 million in 2024 and is expected to reach $421.3 million by 2030 growing at a CAGR of 7.5% during the forecast period. Organ preservation solutions are specialized fluids designed to maintain the viability and function of organs during the period between their removal from a donor and transplantation into a recipient. These solutions help prevent cellular damage, reduce metabolic activity, and protect tissues from ischemic injury, ensuring that the organ remains suitable for transplantation. They are critical in preserving the organ's structure and function for extended periods, typically by cooling the organ and preventing biochemical processes that could lead to organ deterioration.

According to the U.S. Census Bureau, it is projected that 20% of the U.S. population will be aged 65 and older by 2024, leading to a higher incidence of age-related diseases necessitating organ transplants.

Market Dynamics:

Driver:

Increasing incidence of organ failure

The increasing incidence of organ failure, driven by factors such as aging populations, chronic diseases, and lifestyle-related health issues, has significantly boosted the demand for organ transplantation. This, in turn, has fueled the growth of the organ preservation solutions market. As more organs are needed for transplantation, the importance of preserving organ viability for longer durations has led to advancements in preservation technologies and solutions, contributing to market expansion.

Restraint:

Limited availability of organs

The limited availability of organs in the market poses significant challenges, including increased organ transplant waiting times and heightened risks for patients in need. This scarcity leads to a reliance on suboptimal preservation methods, which may reduce organ viability and transplant success rates. Additionally, the shortage contributes to ethical concerns, as demand far exceeds supply, forcing healthcare systems to prioritize patients based on criteria, often leaving vulnerable groups at a disadvantage.

Opportunity:

Growing geriatric population

The growing geriatric population is significantly driving the demand for organ preservation solutions. As the elderly are more prone to organ-related health issues and require organ transplants, the need for effective preservation methods has surged. This demographic shift is spurring advancements in organ preservation technologies, ensuring longer viability and better outcomes for organ transplants. The increasing incidence of age-related diseases and the need for transplantation solutions are key growth factors in this market.

Threat:

High cost of procedures

The high cost of procedures in the market can create significant barriers to accessibility and affordability, particularly in low-resource settings. These expenses may limit the availability of advanced preservation technologies, hindering the timely transport and transplantation of organs. As a result, the success rates of organ transplants could decline, and the overall efficiency of organ donation systems may be compromised, leading to prolonged waiting times and increased mortality rates.

Covid-19 Impact:

The COVID-19 pandemic significantly disrupted the market by delaying elective surgeries and reducing organ donations due to health and safety concerns. Hospitals faced resource shortages, and transportation of organs was hindered by lockdowns and travel restrictions. These challenges led to a backlog in transplants, affecting patient outcomes and reducing the overall demand for preservation solutions. Furthermore, the pandemic strained the supply chain for these critical medical products.

The organ transplantation segment is expected to be the largest during the forecast period

The organ transplantation segment is anticipated to account for the largest market share during the projection period. Effective organ preservation is vital for maintaining organ viability during transportation, ensuring successful transplants. As the number of organ donors grows, the need for innovative preservation solutions intensifies, especially for high-demand organs like kidneys, livers, and hearts. The market's growth is closely tied to advancements in preservation methods that enhance transplant success rates and organ longevity.

The biopreservation segment is expected to have the highest CAGR during the forecast period

The biopreservation segment is expected to have the highest CAGR during the extrapolated period. This approach involves cryopreservation or hypothermic preservation techniques, which protect organs from damage caused by freezing or low temperatures. Biopreservation ensures better outcomes in organ transplantation by prolonging the shelf life of organs, reducing ischemic damage, and improving transplant success rates. Its growing adoption drives innovation and market growth in organ preservation technologies.

Region with largest share:

North America region is anticipated to account for the largest market share during the forecast period. The region benefits from robust research and development in preservation technologies, including hypothermic and normothermic techniques. Government initiatives and funding for organ transplantation further support market growth. North America's high demand for efficient preservation solutions is driven by the need to enhance transplant success rates and reduce organ rejection.

Region with highest CAGR:

Asia Pacific is expected to register the highest growth rate over the forecast period due to the increasing demand for organ transplants. The demand for organ transplants is increasing due to the rising prevalence of organ failure and chronic diseases like diabetes and heart disease. Additionally, the development of advanced preservation methods, such as machine perfusion and cold storage solutions, has led to improved organ viability during transportation and storage.

Key players in the market

Some of the key players in Organ Preservation Solutions market include Thermo Fisher Scientific, Merck, Fisher Scientific, TSE Systems, Sorin Group, Eurobio Scientific, Baxter International, Medtronic, Teva Pharmaceuticals, Asahi Kasei Medical, Hemonetics, Organ Recovery Systems, TransMedics, Perfusion Solutions and Stemcell Technologies.

Key Developments:

In August 2024, Paragonix Technologies has acquired by Getinge, one of the world's leading medical technology companies. A global industry leader in organ transplantation, Paragonix is recognized for the advanced, FDA-approved organ transportation solutions it provides to safeguard the secure transportation of donor organs.

In June 2024, Devyser Diagnostics AB (publ) announced that the company has expanded its exclusive collaboration and distribution agreement with Thermo Fisher Scientific, giving Thermo Fisher exclusive rights to commercialize, under combined brands, Devyser's post-transplant portfolio of NGS products globally.

Organ Types Covered:

  • Kidneys
  • Liver
  • Heart
  • Lungs
  • Pancreas
  • Other Organ Types

Solution Types Covered:

  • Static Preservation Solutions
  • Dynamic Preservation Solutions

Distribution Channels Covered:

  • Direct Sales
  • Distributors/Wholesalers
  • Online Sales & E-Commerce

Applications Covered:

  • Organ Transplantation
  • Medical Research & Development
  • Pharmaceutical Testing
  • Biopreservation
  • Clinical and Diagnostic
  • Organ Recovery & Transportation
  • Other Applications

Regions Covered:

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • New Zealand
    • South Korea
    • Rest of Asia Pacific
  • South America
    • Argentina
    • Brazil
    • Chile
    • Rest of South America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Qatar
    • South Africa
    • Rest of Middle East & Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2022, 2023, 2024, 2026, and 2030
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

  • 2.1 Abstract
  • 2.2 Stake Holders
  • 2.3 Research Scope
  • 2.4 Research Methodology
    • 2.4.1 Data Mining
    • 2.4.2 Data Analysis
    • 2.4.3 Data Validation
    • 2.4.4 Research Approach
  • 2.5 Research Sources
    • 2.5.1 Primary Research Sources
    • 2.5.2 Secondary Research Sources
    • 2.5.3 Assumptions

3 Market Trend Analysis

  • 3.1 Introduction
  • 3.2 Drivers
  • 3.3 Restraints
  • 3.4 Opportunities
  • 3.5 Threats
  • 3.6 Application Analysis
  • 3.7 Emerging Markets
  • 3.8 Impact of Covid-19

4 Porters Five Force Analysis

  • 4.1 Bargaining power of suppliers
  • 4.2 Bargaining power of buyers
  • 4.3 Threat of substitutes
  • 4.4 Threat of new entrants
  • 4.5 Competitive rivalry

5 Global Organ Preservation Solutions Market, By Organ Type

  • 5.1 Introduction
  • 5.2 Kidneys
  • 5.3 Liver
  • 5.4 Heart
  • 5.5 Lungs
  • 5.6 Pancreas
  • 5.7 Other Organ Types

6 Global Organ Preservation Solutions Market, By Solution Type

  • 6.1 Introduction
  • 6.2 Static Preservation Solutions
    • 6.2.1 University of Wisconsin (UW) solution
    • 6.2.2 Collins solution
    • 6.2.3 Celsior solution
    • 6.2.4 Custodiol solution
  • 6.3 Dynamic Preservation Solutions
    • 6.3.1 Normothermic machine perfusion (NMP)
    • 6.3.2 Hypothermic machine perfusion (HMP)

7 Global Organ Preservation Solutions Market, By Distribution Channel

  • 7.1 Introduction
  • 7.2 Direct Sales
  • 7.3 Distributors/Wholesalers
  • 7.4 Online Sales & E-Commerce

8 Global Organ Preservation Solutions Market, By Application

  • 8.1 Introduction
  • 8.2 Organ Transplantation
  • 8.3 Medical Research & Development
  • 8.4 Pharmaceutical Testing
  • 8.5 Biopreservation
  • 8.6 Clinical and Diagnostic
  • 8.7 Organ Recovery & Transportation
  • 8.8 Other Applications

9 Global Organ Preservation Solutions Market, By Geography

  • 9.1 Introduction
  • 9.2 North America
    • 9.2.1 US
    • 9.2.2 Canada
    • 9.2.3 Mexico
  • 9.3 Europe
    • 9.3.1 Germany
    • 9.3.2 UK
    • 9.3.3 Italy
    • 9.3.4 France
    • 9.3.5 Spain
    • 9.3.6 Rest of Europe
  • 9.4 Asia Pacific
    • 9.4.1 Japan
    • 9.4.2 China
    • 9.4.3 India
    • 9.4.4 Australia
    • 9.4.5 New Zealand
    • 9.4.6 South Korea
    • 9.4.7 Rest of Asia Pacific
  • 9.5 South America
    • 9.5.1 Argentina
    • 9.5.2 Brazil
    • 9.5.3 Chile
    • 9.5.4 Rest of South America
  • 9.6 Middle East & Africa
    • 9.6.1 Saudi Arabia
    • 9.6.2 UAE
    • 9.6.3 Qatar
    • 9.6.4 South Africa
    • 9.6.5 Rest of Middle East & Africa

10 Key Developments

  • 10.1 Agreements, Partnerships, Collaborations and Joint Ventures
  • 10.2 Acquisitions & Mergers
  • 10.3 New Product Launch
  • 10.4 Expansions
  • 10.5 Other Key Strategies

11 Company Profiling

  • 11.1 Thermo Fisher Scientific
  • 11.2 Merck
  • 11.3 Fisher Scientific
  • 11.4 TSE Systems
  • 11.5 Sorin Group
  • 11.6 Eurobio Scientific
  • 11.7 Baxter International
  • 11.8 Medtronic
  • 11.9 Teva Pharmaceuticals
  • 11.10 Asahi Kasei Medical
  • 11.11 Hemonetics
  • 11.12 Organ Recovery Systems
  • 11.13 TransMedics
  • 11.14 Perfusion Solutions
  • 11.15 Stemcell Technologies

List of Tables

  • Table 1 Global Organ Preservation Solutions Market Outlook, By Region (2022-2030) ($MN)
  • Table 2 Global Organ Preservation Solutions Market Outlook, By Organ Type (2022-2030) ($MN)
  • Table 3 Global Organ Preservation Solutions Market Outlook, By Kidneys (2022-2030) ($MN)
  • Table 4 Global Organ Preservation Solutions Market Outlook, By Liver (2022-2030) ($MN)
  • Table 5 Global Organ Preservation Solutions Market Outlook, By Heart (2022-2030) ($MN)
  • Table 6 Global Organ Preservation Solutions Market Outlook, By Lungs (2022-2030) ($MN)
  • Table 7 Global Organ Preservation Solutions Market Outlook, By Pancreas (2022-2030) ($MN)
  • Table 8 Global Organ Preservation Solutions Market Outlook, By Other Organ Types (2022-2030) ($MN)
  • Table 9 Global Organ Preservation Solutions Market Outlook, By Solution Type (2022-2030) ($MN)
  • Table 10 Global Organ Preservation Solutions Market Outlook, By Static Preservation Solutions (2022-2030) ($MN)
  • Table 11 Global Organ Preservation Solutions Market Outlook, By University of Wisconsin (UW) solution (2022-2030) ($MN)
  • Table 12 Global Organ Preservation Solutions Market Outlook, By Collins solution (2022-2030) ($MN)
  • Table 13 Global Organ Preservation Solutions Market Outlook, By Celsior solution (2022-2030) ($MN)
  • Table 14 Global Organ Preservation Solutions Market Outlook, By Custodiol solution (2022-2030) ($MN)
  • Table 15 Global Organ Preservation Solutions Market Outlook, By Dynamic Preservation Solutions (2022-2030) ($MN)
  • Table 16 Global Organ Preservation Solutions Market Outlook, By Normothermic machine perfusion (NMP) (2022-2030) ($MN)
  • Table 17 Global Organ Preservation Solutions Market Outlook, By Hypothermic machine perfusion (HMP) (2022-2030) ($MN)
  • Table 18 Global Organ Preservation Solutions Market Outlook, By Distribution Channel (2022-2030) ($MN)
  • Table 19 Global Organ Preservation Solutions Market Outlook, By Direct Sales (2022-2030) ($MN)
  • Table 20 Global Organ Preservation Solutions Market Outlook, By Distributors/Wholesalers (2022-2030) ($MN)
  • Table 21 Global Organ Preservation Solutions Market Outlook, By Online Sales & E-Commerce (2022-2030) ($MN)
  • Table 22 Global Organ Preservation Solutions Market Outlook, By Application (2022-2030) ($MN)
  • Table 23 Global Organ Preservation Solutions Market Outlook, By Organ Transplantation (2022-2030) ($MN)
  • Table 24 Global Organ Preservation Solutions Market Outlook, By Medical Research & Development (2022-2030) ($MN)
  • Table 25 Global Organ Preservation Solutions Market Outlook, By Pharmaceutical Testing (2022-2030) ($MN)
  • Table 26 Global Organ Preservation Solutions Market Outlook, By Biopreservation (2022-2030) ($MN)
  • Table 27 Global Organ Preservation Solutions Market Outlook, By Clinical and Diagnostic (2022-2030) ($MN)
  • Table 28 Global Organ Preservation Solutions Market Outlook, By Organ Recovery & Transportation (2022-2030) ($MN)
  • Table 29 Global Organ Preservation Solutions Market Outlook, By Other Applications (2022-2030) ($MN)

Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.